{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:47:56Z","timestamp":1790470076546,"version":"4.1.0"},"reference-count":47,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T00:00:00Z","timestamp":1460073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Although dasatinib is effective in most imatinib mesylate (IMT)-resistant chronic myeloid leukemia (CML) patients, the underlying mechanism of its effectiveness in eliminating imatinib-resistant cells is only partially understood. This study investigated the effects of dasatinib on signaling mechanisms driving-resistance in imatinib-resistant CML cell line K562 (K562RIMT). Compared with K562 control cells, exsomal release, the phosphoinositide 3-kinase (PI3K)\/protein kinase B (Akt)\/ mammalian target of rapamycin (mTOR) signaling and autophagic activity were increased significantly in K562RIMT cells and mTOR-independent beclin-1\/Vps34 signaling was shown to be involved in exosomal release in these cells. We found that Notch1 activation-mediated reduction of phosphatase and tensin homolog (PTEN) was responsible for the increased Akt\/mTOR activities in K562RIMT cells and treatment with Notch1 \u03b3-secretase inhibitor prevented activation of Akt\/mTOR. In addition, suppression of mTOR activity by rapamycin decreased the level of activity of p70S6K, induced upregulation of p53 and caspase 3, and led to increase of apoptosis in K562RIMT cells. Inhibition of autophagy by spautin-1 or beclin-1 knockdown decreased exosomal release, but did not affect apoptosis in K562RIMT cells. In summary, in K562RIMT cells dasatinib promoted apoptosis through downregulation of Akt\/mTOR activities, while preventing exosomal release and inhibiting autophagy by downregulating expression of beclin-1 and Vps34. Our findings reveal distinct dasatinib-induced mechanisms of apoptotic response and exosomal release in imatinib-resistant CML cells.<\/jats:p>","DOI":"10.3390\/ijms17040531","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T21:02:38Z","timestamp":1460149358000},"page":"531","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells"],"prefix":"10.3390","volume":"17","author":[{"given":"Juan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Hematology, Harbin Medical University Second Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harbin Medical University Second Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aichun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Lymphology, Harbin Medical University Cancer Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Harbin Medical University Second Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianqiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology and Lymphology, Harbin Medical University Cancer Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Harbin Medical University Second Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Harbin Medical University Second Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Hematology, Harbin Medical University Second Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Harbin Medical University Second Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Harbin Medical University Second Hospital, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","article-title":"Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management","volume":"89","author":"Jabbour","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-09-1068","article-title":"Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia","volume":"15","author":"Milojkovic","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clml.2015.03.006","article-title":"Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: An evolving treatment paradigm","volume":"15","author":"Jabbour","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ajh.23419","article-title":"Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition","volume":"88","author":"Simara","year":"2013","journal-title":"Am. J. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/mutage\/geu045","article-title":"The expanding role of mTOR in cancer cell growth and proliferation","volume":"30","author":"Cargnello","year":"2015","journal-title":"Mutagenesis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","article-title":"Regulation of mTORC1 by PI3K signaling","volume":"25","author":"Dibble","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","article-title":"Targeting PI3K\/AKT\/mTOR network for treatment of leukemia","volume":"72","author":"Bertacchini","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2010-12-322537","article-title":"BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription","volume":"118","author":"Sheng","year":"2011","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fimmu.2014.00403","article-title":"Exosomes and autophagy: Coordinated mechanisms for the maintenance of cellular fitness","volume":"5","author":"Baixauli","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/ijc.26217","article-title":"Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis","volume":"130","author":"Taverna","year":"2012","journal-title":"INT. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10456-011-9241-1","article-title":"Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion","volume":"15","author":"Mineo","year":"2012","journal-title":"Angiogenesis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/ijo.2014.2313","article-title":"Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia","volume":"44","author":"Shao","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.4161\/cc.25920","article-title":"Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells","volume":"12","author":"Ciarcia","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.leu.2403898","article-title":"Compensatory PI3-kinase\/Akt\/mTor activation regulates imatinib resistance development","volume":"19","author":"Burchert","year":"2005","journal-title":"Leukemia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"20083","DOI":"10.1074\/jbc.M301642200","article-title":"Exosome release is regulated by a calcium-dependent mechanism in K562 cells","volume":"278","author":"Savina","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2014.00160","article-title":"Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia","volume":"5","author":"Hong","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: A pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20071427","article-title":"The regulation and function of Class III PI3Ks: Novel roles for Vps34","volume":"410","author":"Backer","year":"2008","journal-title":"Biochem. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.tcb.2010.03.002","article-title":"The Beclin 1-VPS34 complex\u2014At the crossroads of autophagy and beyond","volume":"20","author":"Funderburk","year":"2010","journal-title":"Trends Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1078-0432.CCR-10-1613","article-title":"Molecular pathways: BCR-ABL","volume":"18","author":"Cilloni","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00432-014-1803-3","article-title":"Current clinical regulation of PI3K\/PTEN\/Akt\/mTOR signalling in treatment of human cancer","volume":"141","author":"Lim","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1159\/000430167","article-title":"Inhibition of notch signaling promotes the adipogenic differentiation of mesenchymal stem cells through autophagy activation and PTEN-PI3K\/AKT\/mTOR pathway","volume":"36","author":"Song","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-1139-4_1","article-title":"Introduction to Notch signaling","volume":"1187","author":"Yamamoto","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110892","article-title":"Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks","volume":"441","author":"Magnuson","year":"2012","journal-title":"Biochem. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/cc.2.4.433","article-title":"Multiple roles of the PI3K\/PKB (Akt) pathway in cell cycle progression","volume":"2","author":"Liang","year":"2003","journal-title":"Cell Cycle"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2010.04.016","article-title":"BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review","volume":"34","author":"An","year":"2010","journal-title":"Leuk. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance","volume":"96","author":"Mahon","year":"2000","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.V101.2.690","article-title":"BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571","volume":"101","author":"Donato","year":"2003","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/jpet.107.124461","article-title":"Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors","volume":"322","author":"Lee","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-08-3014","article-title":"TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): Phospho-Ser2481 is a marker for intact mTOR signaling complex 2","volume":"69","author":"Copp","year":"2009","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/15384047.2015.1026510","article-title":"Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia","volume":"16","author":"Carneiro","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18632\/oncotarget.1018","article-title":"Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia","volume":"4","author":"Tong","year":"2013","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jconrel.2015.06.029","article-title":"Exosome mediated communication within the tumor microenvironment","volume":"219","author":"Milane","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0854.2007.00677.x","article-title":"Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells","volume":"9","author":"Fader","year":"2008","journal-title":"Traffic"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12964-015-0086-x","article-title":"Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism","volume":"13","author":"Raimondo","year":"2015","journal-title":"Cell Commun. Signal."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/hmg\/8.2.185","article-title":"PTEN is inversely correlated with the cell survival factor Akt\/PKB and is inactivated via multiple mechanismsin haematological malignancies","volume":"8","author":"Dahia","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.leukres.2008.06.023","article-title":"Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562","volume":"33","author":"Yin","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3892\/ol.2014.2014","article-title":"Resveratrol inhibits the phosphatidylinositide 3-kinase\/protein kinase B\/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line","volume":"7","author":"Sui","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3109\/10428190903147637","article-title":"Activation of the p38 MAP kinase pathway is essential for the antileukemic effects of dasatinib","volume":"50","author":"Dumka","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/CAD.0b013e32835a0fbd","article-title":"Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells","volume":"24","author":"Oh","year":"2013","journal-title":"Anticancer Drugs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jcp.25118","article-title":"Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia","volume":"231","author":"Ciarcia","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1756-8722-4-32","article-title":"Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line","volume":"4","author":"Okabe","year":"2011","journal-title":"J. Hematol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.bbamcr.2009.09.011","article-title":"TI-VAMP\/VAMP7 and VAMP3\/cellubrevin: Two v-SNARE proteins involved in specific steps of the autophagy\/multivesicular body pathways","volume":"1793","author":"Fader","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1158\/1078-0432.CCR-08-0461","article-title":"Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells","volume":"14","author":"Okabe","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2867-13-26","article-title":"Beclin1 inhibition promotes autophagy and decreases gemcitabine-induced apoptosis in Miapaca2 pancreatic cancer cells","volume":"13","author":"Li","year":"2013","journal-title":"Cancer Cell Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.cellsig.2013.08.044","article-title":"Activation of integrin \u03b21-focal adhesion kinase-RasGTP pathway plays a critical role in TGF \u03b21-induced podocyte injury","volume":"25","author":"Zhang","year":"2013","journal-title":"Cell Signal."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/4\/531\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:21:59Z","timestamp":1760210519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/4\/531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,8]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4]]}},"alternative-id":["ijms17040531"],"URL":"https:\/\/doi.org\/10.3390\/ijms17040531","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,8]]}}}